Chronic Kidney Disease-Associated Pruritus: A Review

被引:36
作者
Makar, Maria [1 ]
Smyth, Brendan [1 ]
Brennan, Frank [1 ]
机构
[1] St George Hosp, Dept Renal Med, Kogarah, NSW, Australia
关键词
Chronic kidney disease-associated pruritus; Uraemic pruritus; Chronic kidney disease; UREMIC PRURITUS; DOUBLE-BLIND; HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; CHRONIC ITCH; ULTRAVIOLET PHOTOTHERAPY; TOPICAL CAPSAICIN; CROMOLYN SODIUM; CLINICAL-TRIAL; ONDANSETRON;
D O I
10.1159/000518391
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Chronic kidney disease-associated pruritus (CKD-aP), also known as uraemic pruritus, is a disabling symptom for patients and a challenging condition for clinicians. Despite being common amongst end-stage kidney disease (ESKD) patients, it remains underestimated and underdiagnosed. The exact pathogenesis remains largely elusive, which hampers the synthesis of a definite treatment approach. Summary: Chronic pruritus (lasting 6 weeks or more in duration) is a common and potentially disabling symptom in patients with advanced CKD. A unified hypothesis of pathogenesis has not yet been concluded. Studies have shown changes in the immunochemical milieu of the skin in patients with CKD-aP with several inciting stimuli identified. However, other unrecognized factors are likely to be involved. This article will review the current observations and understanding of the postulated pathogenesis of CKD-aP, as well as the evidence for current management strategies. Key Messages: CKD-aP is a common and troubling symptom amongst ESKD patients that is associated with decreased quality of life and poor prognosis. Its exact pathogenesis, at the time of writing, is not well-understood. A stepwise approach is recommended for management. Systematic reviews show the largest body of evidence was found for the effectiveness of gabapentin. Comparison is needed between newly emerging pharmacological agents such as kappa-opioid receptor agonists and more established agents, such as the gabapentinoids. Finally, renal transplantation should be considered in severe and refractory cases who are suitable transplant candidates as it has shown an excellent outcome in most cases.
引用
收藏
页码:659 / 669
页数:11
相关论文
共 99 条
[1]   Treatment of uremic pruritus with narrowband ultraviolet B phototherapy:: An open pilot study [J].
Ada, S ;
Seçkin, D ;
Budakoglu, I ;
Özdemir, FN .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (01) :149-151
[2]   Symptom Burden and Associated Factors in Renal Transplant Patients in the U.K [J].
Afshar, Maryam ;
Rebollo-Mesa, Irene ;
Murphy, Emma ;
Murtagh, Fliss E. M. ;
Mamode, Nizam .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2012, 44 (02) :229-238
[3]   β2-Microglobulin elicits itch-related responses in mice through the direct activation of primary afferent neurons expressing transient receptor potential vanilloid 1 [J].
Andoh, Tsugunobu ;
Maki, Takahito ;
Li, Sikai ;
Uta, Daisuke .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 810 :134-140
[4]   Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study [J].
Aramwit, Pornanong ;
Keongamaroon, Orathai ;
Siritientong, Tippawan ;
Bang, Nipaporn ;
Supasyndh, Ouppatham .
BMC NEPHROLOGY, 2012, 13
[5]   Ondansetron therapy for uremic pruritus in hemodialysis patients [J].
Ashmore, SD ;
Jones, CH ;
Newstead, CG ;
Daly, MJ ;
Chrystyn, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) :827-831
[6]   A STUDY OF BETA-2-MICROGLOBULIN SKIN DEPOSITS IN DIALYZED PATIENTS AND HEALTHY CONTROLS [J].
ASSOUNGA, AG ;
BASCOUL, S ;
CANAUD, B ;
BOUYA, PA ;
VENDRELL, JP ;
SCIOLLA, JP ;
MOURAD, G ;
BALDET, P ;
SERRE, A ;
MION, C .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (06) :556-561
[7]  
Aval SB, 2018, IRAN J KIDNEY DIS, V12, P78
[8]   Randomized, Double-blind Study with Glycerol and Paraffin in Uremic Xerosis [J].
Balaskas, Elias ;
Szepietowski, Jacek C. ;
Bessis, Didier ;
Ioannides, Dimitrios ;
Ponticelli, Claudio ;
Ghienne, Corinne ;
Taberly, Alain ;
Dupuy, Patrick .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (04) :748-752
[9]   Histamine and serotonin in uremic pruritus: Effect of ondansetron in CAPD-pruritic patients [J].
Balaskas, EV ;
Bamihas, GI ;
Karamouzis, M ;
Voyiatzis, G ;
Tourkantonis, A .
NEPHRON, 1998, 78 (04) :395-402
[10]   UREMIC PRURITUS - SKIN DIVALENT ION CONTENT AND RESPONSE TO ULTRAVIOLET PHOTOTHERAPY [J].
BLACHLEY, JD ;
BLANKENSHIP, DM ;
MENTER, A ;
PARKER, TF ;
KNOCHEL, JP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1985, 5 (05) :237-241